Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Carbohydrates
1.2.3 Parenteral Lipid Emulsion
1.2.4 Single Dose Amino Acid Solution
1.2.5 Trace Elements
1.2.6 Vitamins and Minerals
1.3 Market by Application
1.3.1 Global Peripheral Parenteral Nutrition (PPN) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Home
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Parenteral Nutrition (PPN) Market Perspective (2018-2033)
2.2 Peripheral Parenteral Nutrition (PPN) Growth Trends by Region
2.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Peripheral Parenteral Nutrition (PPN) Historic Market Size by Region (2018-2023)
2.2.3 Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2024-2033)
2.3 Peripheral Parenteral Nutrition (PPN) Market Dynamics
2.3.1 Peripheral Parenteral Nutrition (PPN) Industry Trends
2.3.2 Peripheral Parenteral Nutrition (PPN) Market Drivers
2.3.3 Peripheral Parenteral Nutrition (PPN) Market Challenges
2.3.4 Peripheral Parenteral Nutrition (PPN) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue
3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue (2018-2023)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Players (2018-2023)
3.2 Global Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Parenteral Nutrition (PPN) Revenue
3.4 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio
3.4.1 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) Revenue in 2022
3.5 Peripheral Parenteral Nutrition (PPN) Key Players Head office and Area Served
3.6 Key Players Peripheral Parenteral Nutrition (PPN) Product Solution and Service
3.7 Date of Enter into Peripheral Parenteral Nutrition (PPN) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Type
4.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Type (2018-2023)
4.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2024-2033)
5 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Application
5.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Application (2018-2023)
5.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Peripheral Parenteral Nutrition (PPN) Market Size (2018-2033)
6.2 North America Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2018-2023)
6.4 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Parenteral Nutrition (PPN) Market Size (2018-2033)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2018-2023)
7.4 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size (2018-2033)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2018-2023)
8.4 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Parenteral Nutrition (PPN) Market Size (2018-2033)
9.2 Latin America Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2018-2023)
9.4 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size (2018-2033)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2018-2023)
10.4 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofarma
11.1.1 Eurofarma Company Detail
11.1.2 Eurofarma Business Overview
11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Introduction
11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.1.5 Eurofarma Recent Development
11.2 Corporacion De Laboratorios Farmaceuticos
11.2.1 Corporacion De Laboratorios Farmaceuticos Company Detail
11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Introduction
11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Detail
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Introduction
11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.3.5 Baxter International Inc. Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Detail
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Introduction
11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.4.5 Kelun Pharma Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Detail
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Introduction
11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.5.5 B. Braun Recent Development
11.6 Fresenius
11.6.1 Fresenius Company Detail
11.6.2 Fresenius Business Overview
11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Introduction
11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.6.5 Fresenius Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Detail
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer (Hospira)
11.8.1 Pfizer (Hospira) Company Detail
11.8.2 Pfizer (Hospira) Business Overview
11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Introduction
11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.8.5 Pfizer (Hospira) Recent Development
11.9 Ostuka Pharmaceutical
11.9.1 Ostuka Pharmaceutical Company Detail
11.9.2 Ostuka Pharmaceutical Business Overview
11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.9.5 Ostuka Pharmaceutical Recent Development
11.10 Laboratorios Biogalenic
11.10.1 Laboratorios Biogalenic Company Detail
11.10.2 Laboratorios Biogalenic Business Overview
11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Introduction
11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.10.5 Laboratorios Biogalenic Recent Development
11.11 Laboratorios Finlay
11.11.1 Laboratorios Finlay Company Detail
11.11.2 Laboratorios Finlay Business Overview
11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Introduction
11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.11.5 Laboratorios Finlay Recent Development
11.12 Grifols International
11.12.1 Grifols International Company Detail
11.12.2 Grifols International Business Overview
11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Introduction
11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.12.5 Grifols International Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Detail
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Introduction
11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.13.5 Fresenius Kabi Recent Development
11.14 Sichuan Kelun Pharmaceutical
11.14.1 Sichuan Kelun Pharmaceutical Company Detail
11.14.2 Sichuan Kelun Pharmaceutical Business Overview
11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Carbohydrates
Table 3. Key Players of Parenteral Lipid Emulsion
Table 4. Key Players of Single Dose Amino Acid Solution
Table 5. Key Players of Trace Elements
Table 6. Key Players of Vitamins and Minerals
Table 7. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2018-2023)
Table 11. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2024-2033)
Table 13. Peripheral Parenteral Nutrition (PPN) Market Trends
Table 14. Peripheral Parenteral Nutrition (PPN) Market Drivers
Table 15. Peripheral Parenteral Nutrition (PPN) Market Challenges
Table 16. Peripheral Parenteral Nutrition (PPN) Market Restraints
Table 17. Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players (2018-2023)
Table 19. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2022)
Table 20. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Peripheral Parenteral Nutrition (PPN) Product Solution and Service
Table 24. Date of Enter into Peripheral Parenteral Nutrition (PPN) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2018-2023)
Table 28. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2024-2033)
Table 30. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2018-2023)
Table 32. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2024-2033)
Table 34. North America Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2024-2033) & (US$ Million)
Table 49. Eurofarma Company Detail
Table 50. Eurofarma Business Overview
Table 51. Eurofarma Peripheral Parenteral Nutrition (PPN) Product
Table 52. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 53. Eurofarma Recent Development
Table 54. Corporacion De Laboratorios Farmaceuticos Company Detail
Table 55. Corporacion De Laboratorios Farmaceuticos Business Overview
Table 56. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product
Table 57. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 58. Corporacion De Laboratorios Farmaceuticos Recent Development
Table 59. Baxter International Inc. Company Detail
Table 60. Baxter International Inc. Business Overview
Table 61. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product
Table 62. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 63. Baxter International Inc. Recent Development
Table 64. Kelun Pharma Company Detail
Table 65. Kelun Pharma Business Overview
Table 66. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product
Table 67. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 68. Kelun Pharma Recent Development
Table 69. B. Braun Company Detail
Table 70. B. Braun Business Overview
Table 71. B. Braun Peripheral Parenteral Nutrition (PPN) Product
Table 72. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 73. B. Braun Recent Development
Table 74. Fresenius Company Detail
Table 75. Fresenius Business Overview
Table 76. Fresenius Peripheral Parenteral Nutrition (PPN) Product
Table 77. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 78. Fresenius Recent Development
Table 79. Teva Pharmaceutical Industries Company Detail
Table 80. Teva Pharmaceutical Industries Business Overview
Table 81. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product
Table 82. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Recent Development
Table 84. Pfizer (Hospira) Company Detail
Table 85. Pfizer (Hospira) Business Overview
Table 86. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product
Table 87. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 88. Pfizer (Hospira) Recent Development
Table 89. Ostuka Pharmaceutical Company Detail
Table 90. Ostuka Pharmaceutical Business Overview
Table 91. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
Table 92. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 93. Ostuka Pharmaceutical Recent Development
Table 94. Laboratorios Biogalenic Company Detail
Table 95. Laboratorios Biogalenic Business Overview
Table 96. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product
Table 97. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 98. Laboratorios Biogalenic Recent Development
Table 99. Laboratorios Finlay Company Detail
Table 100. Laboratorios Finlay Business Overview
Table 101. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product
Table 102. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 103. Laboratorios Finlay Recent Development
Table 104. Grifols International Company Detail
Table 105. Grifols International Business Overview
Table 106. Grifols International Peripheral Parenteral Nutrition (PPN) Product
Table 107. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 108. Grifols International Recent Development
Table 109. Fresenius Kabi Company Detail
Table 110. Fresenius Kabi Business Overview
Table 111. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product
Table 112. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 113. Fresenius Kabi Recent Development
Table 114. Sichuan Kelun Pharmaceutical Company Detail
Table 115. Sichuan Kelun Pharmaceutical Business Overview
Table 116. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
Table 117. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2018-2023) & (US$ Million)
Table 118. Sichuan Kelun Pharmaceutical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Parenteral Nutrition (PPN) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Peripheral Parenteral Nutrition (PPN) Market Share by Type: 2022 VS 2033
Figure 3. Carbohydrates Features
Figure 4. Parenteral Lipid Emulsion Features
Figure 5. Single Dose Amino Acid Solution Features
Figure 6. Trace Elements Features
Figure 7. Vitamins and Minerals Features
Figure 8. Global Peripheral Parenteral Nutrition (PPN) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Peripheral Parenteral Nutrition (PPN) Market Share by Application: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Home Case Studies
Figure 12. Peripheral Parenteral Nutrition (PPN) Report Years Considered
Figure 13. Global Peripheral Parenteral Nutrition (PPN) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Peripheral Parenteral Nutrition (PPN) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region: 2022 VS 2033
Figure 16. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players in 2022
Figure 17. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue in 2022
Figure 19. North America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2018-2033)
Figure 21. United States Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Peripheral Parenteral Nutrition (PPN) Market Share by Country (2018-2033)
Figure 25. Germany Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Share by Region (2018-2033)
Figure 33. China Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2018-2033)
Figure 41. Mexico Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Share by Country (2018-2033)
Figure 45. Turkey Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 48. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 49. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 50. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 51. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 52. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 53. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 54. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 55. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 56. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 57. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 58. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 59. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 60. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed